Genitourinary Syndrome: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
'''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}</div>'''This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work!''' | '''Top Contributors''' - {{Special:Contributors/{{FULLPAGENAME}}}}</div>'''This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work!''' | ||
== | == Introduction == | ||
Genitourinary syndrome it was first introduced in 2014 it is a chronic condition affect women after menopause. GSM or as known previously a vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy. | |||
It is a chronic progressive conditions that describe the changes result from the decereas in estrogen level after menopause on vulvovaginal and lower urinary tract. | |||
the majority may be affected after menopause but about 15%of women may have symptoms premenopause . and may women consider it a normal process with aging process and they could not seek help so it remains underdiagnosed. | |||
They do not consider it a condition need help. So they need medical awareness of their conditions<ref>Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020 Apr 8;12(4).</ref>. | |||
== Mechanism of Injury / Pathological Process<br> == | == Mechanism of Injury / Pathological Process<br> == | ||
Revision as of 23:08, 17 October 2022
Top Contributors - Khloud Shreif, Temitope Olowoyeye and Lucinda hampton
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work!
Introduction[edit | edit source]
Genitourinary syndrome it was first introduced in 2014 it is a chronic condition affect women after menopause. GSM or as known previously a vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy.
It is a chronic progressive conditions that describe the changes result from the decereas in estrogen level after menopause on vulvovaginal and lower urinary tract.
the majority may be affected after menopause but about 15%of women may have symptoms premenopause . and may women consider it a normal process with aging process and they could not seek help so it remains underdiagnosed.
They do not consider it a condition need help. So they need medical awareness of their conditions[1].
Mechanism of Injury / Pathological Process
[edit | edit source]
add text here relating to the mechanism of injury and/or pathology of the condition
Clinical Presentation[edit | edit source]
add text here relating to the clinical presentation of the condition
Diagnostic Procedures[edit | edit source]
add text here relating to diagnostic tests for the condition
Outcome Measures[edit | edit source]
add links to outcome measures here (see Outcome Measures Database)
Management / Interventions
[edit | edit source]
add text here relating to management approaches to the condition
Differential Diagnosis
[edit | edit source]
add text here relating to the differential diagnosis of this condition
Resources
[edit | edit source]
add appropriate resources here
References[edit | edit source]
- ↑ Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020 Apr 8;12(4).
